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Cell-mediated immune mechanisms underlying 
discordant xenograft  rejection are poorly character- 
ized. In our study, using a human to  rat xenogeneic 
ex vivo  model,  we  show that a fraction of human 
lymphocytes,  when  perfused through the coronary 
system of a rat  heart, rapidly and specifically ad- 
heres to  the vascular endothelium and  infiltrates 
the myocardium.  Lymphocyte  phenotypic analysis 
before and after perfusion, as well as  the use of 
purified cell subpopulations, demonstrate prefer- 
ential adhesion of CD3- CD16+ NK cells. NK cell 
adhesion occurs via xenoreactive antibody-depend- 
ent and -independent pathways, because the selec- 
tive removal of human IgG from the perfusion  buffer 
markedly reduces but does not completely abrogate NK cell sequestration. However, T lymphocytes are 
retained in the xenoorgan via an antibody-inde- 
pendent pathway, as assessed by the lack of influ- 
ence of IgG removal.  Leukocyte integrins appear to 
play a crucial role  in  mediating adhesion of both 
lymphocyte subsets, because the pretreatment of 
lymphocytes  with  anti-CD1 la ,  anti-CD1 lb, and  anti- 
CD18 antibodies markedly reduces their retention 
into the xenogeneic organ. Retained human lympho- 
cytes mediate  rapid and direct damage of the xe- 
noorgan, as demonstrated by histologic and func- 
tional  alterations of the endothelium, impaired vas- 
cular resistance and in vitro lysis of rat endothelial 
cells by human NK cells. Taken together, these find- 
ings suggest a role  for  cell-mediated mechanisms in 
the rapid  recognition and rejection of vascularized 
xenografts. 
Rejection of vascularized xenografts is universally ob- 
served  when  discordant  species are used as donor and 
recipient (1). Hyperacute rejection takes place within 
minutes to  hours  and is thought  to  be mediated by the 
recipient's preformed natural antibodies (2, 3). mostly 
IgM (4). that recognize a family of membrane glycopro- 
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teins expressed by vascular  endothelial cells (5) and  ac- 
tivate  the complement and blood clotting cascades  (6, 7). 
Evidence for these  mechanisms is provided  by the obser- 
vation of IgM and complement factors deposited onto 
xenogeneic endothelial cells (8), by the  results of Ig deple- 
tion and passive  reconstitution  experiments (9, 10) and 
by data showing that hyperacute rejection takes place 
only after neovascularization of nonvascular  xenografts 
by donor-derived endothelium (1 1). The  tissue specificity 
of natural antibodies has not been extensively defined. 
However, several  experimental models (human to pig, rat 
to  guinea pig) indicate that  natural antibodies  preferen- 
tially recognize a heterogeneous group of membrane gly- 
coproteins expressed by endothelial cells, RBC, leuko- 
cytes,  platelets,  and kidney tubular  and mesangial cells 
Due to the  hyperacute  nature of the antibody-mediated 
rejection, it is unclear  whether cell-mediated recognition 
of xenogeneic determinants plays  a  significant role in the 
rejection process. In this regard, in vitro studies suggest 
that xenoantigen recognition by T lymphocytes might 
take place both  in  concordant and  in discordant combi- 
nations  (1 3, 16).  These  studies, however, explore events 
that need days or weeks to occur, and might not be 
meaningful in predicting the outcome of the hyperacute 
rejection. Finally,  a role for NK cells in  the recognition of 
vascularized grafts  has been recently suggested (1 7). 
To evaluate the early cellular events of xenogeneic 
recognition, we have  introduced  a novel ex vivo approach 
in which an  isolated rat  heart is perfused  with human 
PBL. We show that a  fraction of human lymphocytes is 
rapidly and specifically retained  in the  heart:  this phe- 
nomenon is due  to  xenoreactive  antibody-dependent and 
independent  adhesion of human lymphocytes to  vascular 
endothelial cells and subsequent  infiltration of the xe- 
noorgan. Phenotypic and histologic analysis of lympho- 
cyte subpopulations  after  circulation  through  the  heart, 
as well as perfusion  with selected lymphocyte subsets, 
reveal a preferential sequestration of NK cells in the 
xenoorgan. Moreover, morphologic analysis of the per- 
fused  organs,  evaluation of the vascular  resistance  and 
in vitro assays of the NK cell-mediated lytic activity on 
rat endothelial  targets,  suggest a role for human lympho- 
cytes  in  mediating early functional  damage of the xeno- 
geneic organ. We propose that cell-mediated effector 
mechanisms are involved in the rapid recognition and 
rejection of vascularized xenoorgans. 
(5, 12). 
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MATERIALS  AND  METHODS 
Antibodies to human CD Ag. Anti-CD3 (Leu 4; IgGl) and  anti- 
CD16 (Leu 1 IC: IgGl) were purchased from Becton Dickinson (Moun- 
tain View, CAI. Anti-CD45 RB (PD7/26 and  2B/11, both IgGl) were 
purchased  from Dako (Hagersten,  Denmark). Anti-CD1 la  (TS  1.22: 
1gG1) and anti-CD18  (TS1.18: IgGl) were kindgiftsof T. A. Springer 
(The Center for Blood Research, Harvard Medical School, Boston, 
MA]. Anti-CD1 l b  (44a; IgG1) was kindly provided by A. Mantovani 
(Institutem NEGRI. Milano, Italy). Anti-human &-microglobulin 
(L368; IgGl)  was  purchased  from American Type Culture Collection 
(Rockville. MA]. 
Isolation and perfusion of rat hearts. Sprague-Dawley NOS 
outbred or (for syngeneic perfusion experiments) Lew/Ola inbred 
rats  (250-280 g, Nossan Srl, Milan, Italy) were anesthetized by i.p. 
injection of heparinized  sodium thiopental  and  the  heart  was isolated 
and mounted onto the Langendorff apparatus system (18). The 
perfusing  buffer  (144.1 mM NaCl, 4.7 mM KC1, 1.2 mM KH2P04, 0.5 
mM EDTA, 1.2 mM Na2S04, 3 mM CaC12, 1.2 mM MgCI2, 16.6 mM 
glucose, and  10 mM HEPES (Sigma Chemical Co., St. Louis, MO)  pH 
7.4,37T)  was oxygenated (100% 02) in a membrane oxygenator and 
circulated at  a flow rate of 15  ml/min by a roller pump.  After heart 
stabilization (20  min). 80 ml of the  buffer were  recirculated through 
the  system. Upon addition of the cell suspension  (final  concentration 
1 O6 cells/ml),  1 -ml aliquots of the  circulating medium  were collected 
a t  different times from the  efferent limb of the perfusion apparatus 
for cell count  and  characterization. Cell counts were  performed by 
two investigators using a standard hemocytometer. Experiments 
were carried out for up to 60 min. The heart performance was 
monitored during  the whole time course of the  experiment by record- 
ing coronary pressure by a pressure  transducer  (Harvard  Apparatus 
model 52-9966, Natick. MA) inserted between the pump and the 
heart. 
PBL were isolated from buffy coats  obtained from  the local blood 
Isolation of human PBL and cell subset purijication. Human 
center by centrifugation on density gradient (Lymphoprep. Phar- 
macia, Uppsala. Sweden). Mononuclear  cells  were subsequently 
washed  three  times in PBS and routinely  depleted of macrophages 
by two rounds of adhesion on plastic Petri dishes and passage 
through nylon wool column. Macrophage depletion was routinely 
performed, as it was observed that  these cells  nonspecifically adhere 
to  the Langendorff apparatus  and,  therefore,  make  the evaluation 
of cell binding to  the  heart impossible. Cells were resuspended  in 
the perfusion buffer;  heat-inactivated  serum from different  sources 
was added to the buffer solution at  a concentration of 2% v/v. 
Monocyte-depleted lymphocytes were further purified by negative 
selection using a panning  technique. Briefly, cells  were preincubated 
with  either anti-CD16 or anti-CD3 mAb for 30 min on  ice, washed 
in cold  PBS. and  incubated  on Petri dishes  that  had been previously 
coated with 10 pglml goat anti-mouse Ig antiserum. Nonadherent 
cells were collected by gently washing  the  plates  and used when 
indicated. Purified subsets obtained by this technique routinely 
contained  less  than 3% of the  contaminating population. 
Isolation of rat  lymphocytes.  Rats were killed and  the  spleen  was 
surgically removed: splenocytes were obtained by perfusing the 
spleen at  high pressure  with  tissue  culture medium (consisting of 
10%  heat inactivated FCS in RPMI 1640  supplemented  with 2 mM 
 glutamine. 100 U/ml penicillin, and  100 pglml streptomycin 
(GIBCO. Grand Island. NY) through a 21-gauge needle. Cells were 
pelleted and the E lysed with a brief incubation in ammonium 
chloride.  Splenocytes  were then centrifuged and  counted. Cell via- 
bility after this procedure was always >95%. Macrophages were 
depleted as described  above. 
human serum  was selectively depleted of IgG by affinity chromatog- 
IgC depletion of human serum. In some experiments, pooled 
raphy on Sepharose-conjugated protein G. Briefly, human serum 
was incubated at room temperature over a prepacked column of 
Sepharose-conjugated  protein G (LKB Pharmacia. Uppsala, Sweden) 
for  30 min at  room temperature  and eluted  with PBS according to 
the  manufacturer's  instructions. Electrophoresis of the eluted serum 
and immunoelectrophoretic analysis confirmed a reduction in  the 
concentration of IgG from an average of 1500  to <5 mgldl. Serum 
The total concentration  and  the electrophoretic profile of the  other 
IgM concentration  was only marginally affected by this procedure. 
main  components of the  serum were not influenced by such  treat- 
ment. 
Phenotypic  analysis. Phenotypic analysis of the recovered lym- 
phocyte subpopulations  was performed by direct (using FITC-con- 
jugated antibodies) or indirect (using a FITC-conjugated goat anti- 
mouse IgG antiserum, Zymed, CA) immunofluorescence. Samples 
were  analyzed  on  a FACS (FACS IV Becton Dickinson, Emeryville, 
CAI. Forward and  90"  scatter profiles were  evaluated and  no signif- 
icant difference was recorded between human  and  rat lymphocytes. 
Rabbit anti-human IgG and IgM antisera were purchased from Dako 
and used in the immunohistochemistry studies. The relative per- 
centages of LFA-ld"" and LFA-lb"gh' cells  were  determined by cyto- 
fluorographic analysis performed after  calibration of the flow cytom- 
eter  with labeled microspheres as previously described (19). 
Antibody  pretreatment of human  lymphocytes. In some  experi- 
ments  human lymphocytes  were pretreated with mAb to  assess  the 
role of different molecules in mediating adhesion to xenogeneic 
endothelium. Briefly, cells  were preincubated with saturating con- 
centrations  (10 pg/ml) of mAb for  30 min  on ice. Cells were subse- 
quently  washed in cold PBS and  resuspended  in  the  perfusing  buffer 
containing 2% unfractionated or IgG-depleted human serum and 
used in  the perfusion protocol. 
Histology and  immunohistochemistry. At the  end of the perfu- 
sion,  the  heart  was removed from the  apparatus  and  samples of the 
organ were processed either by fixation in 10% paraformaldehyde 
in PBS or by snap freezing in precooled isopentane  and stored at  
-80°C until  used. Conventional histology (hematoxylin-eosin stain- 
ing) and immunohistochemistry studies were carried out. Tissue 
sections were incubated with  various antibodies  and  subsequently 
stained with  peroxidase-conjugated  goat anti-mouse Ig antiserum or 
rabbit  anti-human IgG or IgM polyclonal antisera (Dako). Sections 
were developed with 3.3'diaminobenzidine  tetrahydrochloride (5 mg 
in 10 ml Tris buffer, pH 7.4, H202 0.03%) and analyzed. Tissue 
specimens from different  organs of four outbred rats were collected 
for  immunohistochemical characterization of the binding specificity 
of human anti-rat natural antibodies. Briefly, specimens of the 
vested and  snap-frozen as described above. Sections were incubated 
heart, spleen, liver. lung, kidney, pancreas,  and muscle were har- 
a t  room temperature  with  buffer  alone or serial  dilutions of pooled 
human  serum  (1/50  to  1/500). washed in PBS. stained with peroxi- 
dase-conjugated rabbit  anti-human IgG or IgM antisera,  and devel- 
oped as described  above. 
Evaluation  ofendothelial  cell  damage. At the  end of the various 
experiments,  organs were  perfused  with colloidal carbon black so- 
lution (Rotring, Germany) (1/200 v/v in KRH buffer] for 4 min. 
Samples were  immediately harvested for histology and electron mi- 
croscopy. 
Electron microscopy. Specimens were fixed for 3 h  in 2.5% glu- 
taraldehyde, postfixed in 1% osmium tetroxide, and embebbed in 
epoxy resin.  Sections were  obtained  with  a Reichert-Jung Ultracut 
(Vienna,  Austria) ultramicrotome and examined with a Zeiss CEM 
902 (Carl Zeiss, Oberkochen,  Germany) electron microscope. 
Endothelial cell cultures. Primary rat endothelial cell cultures 
were established in vitro. Briefly, animals were killed and  aortas 
were  surgically removed. The  intimal  surface  was exposed and  thor- 
oughly rinsed with PBS. Collagenase digestion of the endothelial 
layer was carried out for 30 min at  37°C (Collagenase type VI) 
(Sigma). The  intimal  surface  was  then gently scraped with  a  scalpel 
blade and  the endothelium pelleted by centrifugation. Cells were 
gently dissociated by passage  through a 21-gauge needle and cul- 
tured  in 25-cm2 tissue  culture  flasks (Bibby-Corning, Staffordshire, 
UK) in DMEM 20% FCS. Confluent cultures were trypsinized and 
subcultured  in  flat bottom 96-well plates for the cytotoxicity assays. 
Endothelial cell monolayers were identified by morphologic struc- 
tural (typical  cobble-stone appearance]  and  ultrastructural criteria. 
Cell-mediated  cytotoxicity. Cell-mediated cytotoxicity was eval- 
cell monolayers  were labeled with "Cr (5 pCi/well) in DMEM 10% 
uated in a standard 51Cr release assay. Briefly, confluent endothelial 
FCS for 60 min at 37°C. Unincorporated 51Cr was  then removed by 
washing  the monolayers  with 200 pl of warm medium four times. 
Human NK cells  were added to  the 51Cr labeled endothelial  cells to 
achieve final effector to target ratios of 30:l.  10:l. 3:l. and  1:l. 
Experiments were carried out in DMEM in the presence of either 
10%  heat-inactivated pooled human  serum or 10%  heat-inactivated 
rat  serum. After 4  h of incubation,  supernatants were harvested  and 
counted in a y-counter  (Packard  Instruments, Downers Grove, IL). 
Percent cytotoxicity was calculated  according to  the following for- 
mula: 
% cytotoxicity = (experimental release - spontaneous release)/ 
[maximum  release - spontaneous release) X 100. 
Statistical  analysis.  Student's  t-test  was used in  the  statistical 
evaluation of the  data. 
RESULTS  AND  ISCUSSION 
This study was designed to investigate the earliest 
stages of cellular  immune recognition of discordant  xen- 
ogeneic vascularized organs. We sought to analyze these 
events  in an experimental  system that closely mimics the 
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in vivo situation,  particularly for the hemodynamic and 
shear forces that affect  the recognition of donor capillary 
endothelium by circulating recipient lymphocytes. For 
this purpose, we used the Langendorff rat  heart perfusion 
model, which was originally devised to study cardiac 
contractile performance and metabolism (18). In this 
model, an oxygenated buffer  containingglucose as energy 
substrate is injected at  constant flow through a cannula 
inserted in the ascending aorta. Retrograde perfusion 
keeps  the  aortic valve closed, just as in  the  in  situ  heart 
during diastole, and  the  perfusate is displaced through 
the coronary arteries. Coronary pressure is recorded dur- 
ing  the experiment as index of the  vascular  resistance, 
because the flow is kept constant by means of a  pump. 
The perfusate  reaches the coronary sinus  and  hence  the 
right  atrium,  drops off the  heart,  and is collected for a 
subsequent cycle. We adapted  this model to the study of 
lymphocyte perfusion by using  a  continuous  recircula- 
tion apparatus (flow rate 15 ml/min) in which lympho- 
cytes were injected at   an initial  concentration of 1 O6 cells/ 
ml and  the perfusing  buffer was  maintained at  constant 
temperature (37OC). 
Human  lymphocytes  are  rapidly  and  selectively  re- 
tained in xenogeneic  organ:  contribution of xenoreac- 
tIue antibodies. The  concentration of lymphocytes in  the 
perfusate  was  evaluated at 10-min  intervals  (correspond- 
ing to two complete perfusion cycles). When the xenoge- 
neic combination was used (Le., human lymphocytes in 
the presence of 2% heat-inactivated human serum), a 
rapid  decrease  in the cell concentration in the coronary 
outflow was recorded (Fig. la). Lymphocyte sequestra- 
tion in the  heart  was maximal after  the  first two cycles 
and continued  in  subsequent cycles, reaching an  appar- 
ent plateau between the 8th and the 10th passage 
through the coronary system. Xenogeneic lymphocyte 
witholding was markedly reduced on removal of  IgG from 
human  serum (Fig. la). The  rate of human lymphocyte 
sequestration  in  the presence of rat  serum or xenogeneic 
non-human  serum (e.g., bovine) was comparable  to the 
one observed using IgG-depleted human  serum  (not 
a h 
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Figure 1 .  Circulating human lymphocytes are retained into the rat 
rat lymphocytes (round  symbols) were circulated through the heart at an 
heart. a, Xenogeneic human lymphocytes (square  symbols) or syngeneic 
initial concentration of lo6 cells/ml in the presence of 2% unfractionated 
(filled  symbols) or IgG-depleted (empty  symbols) heat-inactivated serum 
homologous to the perfusing lymphocytes: b.  highly purified CD16TD3- 
were circulated through the heart at an initial concentration of lo6 cells/ 
[square  symbols) or CD16-CD3+ (round  symbols) human lymphocytes 
r n l  in the presence of 2% unfractionated lfilled  symbols) or IgG-depleted 
(empty  symbols) heat-Inactivated human serum. Cell counts were per- 
formed  in the outflow at 10-min intervals. Results are expressed as mean 
kSD of four separate experiments. 
shown). 
The  importance of the genetic  disparity between the 
perfused  organ and  the circulating lymphocytes in  deter- 
mining their  disappearance from the  perfusate  was eval- 
uated  using lymphocytes syngeneic  to the perfused or- 
gan. Under these conditions,  no cell sequestration  was 
observed,  regardless of the source of the  serum added to 
the buffer (Fig. 1 a). The  nonlinear  decrease  in xenogeneic 
lymphocyte concentration during perfusion of the rat 
heart,  and  the virtual  absence of cell sequestration  in the 
syngeneic  combination,  argue  against  a nonspecific loss 
of cells in  the system. The lack of sequestration  in  the 
syngeneic  experiments  suggests that a specific recogni- 
tion of xenodeterminants  expressed  on  vascular  endothe- 
lium by circulating human lymphocytes is indeed respon- 
sible for their disappearance from the perfusate. The 
presence of IgG homologous to the circulating lympho- 
cytes maximizes their  retention  into  the xenogeneic or- 
gan.  This evidence argues  in favor of a specific interac- 
tion  between  preexisting  antibodies and xenogeneic de- 
terminants, as the  enhancing effect of serum is abrogated 
by the selective depletion of IgG. Homology between Ig 
and circulating lymphocytes also  appears to  be  essential, 
as the  use of sera  unrelated to  both the species  under 
study is devoid of any effect  on the  rate of lymphocyte 
sequestration  (not  shown). 
CD16+CD3- NK cells are predominant lymphocyte 
subset infiltrating xenogeneic organ. The enhancing 
effect of Ig described above can be explained by one of 
two hypotheses: xenoreactive antibodies  mediate  a  func- 
tional modulation or induce a direct  damage of endothe- 
lial cells, resulting in increased permeability or in the 
induction of adhesiveness toward circulating lympho- 
cytes; alternatively, endothelial cell-bound Ig opsonize 
capillary  endothelia  making them accessible to recogni- 
tion by lymphocytes bearing surface Ig receptors. The 
former hypothesis implies a nonselective retention of 
lymphocytes into the xenogeneic organ. The latter re- 
strains  the antibody-mediated enhancement of cell se- 
questration  to lymphocytes expressing  membrane FcR. 
To distinguish  between these two possibilities, PBL were 
separated by negative selection based on the reciprocal 
expression of the CD16  (low affinity FcyR) and  the CD3 
markers.  The selected subsets were perfused  through the 
coronary system in the presence of unfractionated or 
IgG-depleted  homologous serum. In the presence of ho- 
mologous IgG,  CD16+CD3- lymphocytes underwent  dra- 
matic  sequestration  in  the  xenoorgan,  with  up  to 90% of 
the  input population disappearing  from  the outflow 
within 10 perfusion cycles (Fig. 1 b) .  CD16-CD3+ cells 
showed a less  striking,  but still significant  decrease,  with 
an  average 32% reduction after 10 passages  in  four  sep- 
arate experiments (Fig. 1 b) .  Removing IgG from the 
serum induced a marked decrease in the fraction of 
CD16+CD3- cells witheld in  the  heart,  whereas  the  se- 
questration of CD16-CD3+ cells was only marginally af- 
fected. These data suggest a causative role of homolo- 
gous,  xenoreactive IgG in the  sequestration of FcyR pos- 
itive lymphocytes and make it unlikely that vascular 
endothelium permeability is nonspecifically  increased by 
the binding of heterophylic antibodies, at least in the 
short  term. A significant  antibody-independent  retention 
of CD16”  CD3+ lymphocytes was  consistently observed, 
implying that a fraction of FcyR negative T cells is ca- 
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pable of rapid and specific recognition of the xenogeneic 
endothelium. 
Immunohistochemical analysis  was conducted to ob- 
tain in situ evidence for the phenomena observed when 
rat  hearts were perfused  with  unseparated human lym- 
phocytes in the presence of homologous serum. Figure 2 
shows  human lymphocytes (stained  with an  anti-human 
common leukocyte Ag mAb) adhering to the capillary 
endothelium and  infiltrating  the myocardium (A and B). 
Endothelial cells appear swollen in many microscopic 
fields,  suggesting an anatomical  damage of the  vascular 
intimal layer (B). A significant proportion of the  infiltrat- 
ing lymphocytes react  with an anti-human CD16 anti- 
body (C). D demonstrates that capillary endothelium of 
rat hearts perfused with 2% heat-inactivated human 
serum  stains brightly and diffusely with an anti-human 
IgG antiserum.  This  suggests that  the Ig-dependent cell 
sequestration observed in the xenogeneic lymphocyte 
perfusion  studies is a  consequence of xenoreactive anti- 
bodies of the G isotype binding to the endothelial cell 
lining of coronary vessels. A similar histologic pattern 
was observed with an  anti-human IgM antiserum (not 
shown). Control experiments consisted of perfusion of 
rat  hearts with buffer and  subsequent  staining of tissue 
specimens with rabbit  anti-human Ig antiserum. Nonspe- 
cific binding of anti-human Ig antiserum on cardiac en- 
dothelium was never observed (see below). Myocardial 
sections  obtained  from  syngeneic lymphocyte perfusion 
experiments  always failed to show rat lymphocytes ad- 
hering to the vascular endothelium or infiltrating the 
myocardial fibers (not shown). Endothelial cells never 
appeared swollen or anatomically damaged in this  syn- 
geneic combination. 
Xenoreactive human antibodies preferentially rec- 
ognize vascular endothelium. To assess whether the 
binding of human natural antibodies to rat cells is a 
general  phenomenon  (i.e., human  natural antibodies 
bind rat cells without any  tissue specificity) or it is re- 
stricted  to structures selectively expressed by vascular 
endothelial cells, specimens from various tissues were 
obtained, processed, and stained as described in Mate- 
rials and Methods. Table I shows that reactivity is ob- 
served toward small  vessels of most organs  (lung,  kidney, 
and muscle). The only nonvascular structures specifi- 
cally recognized by the  human  natural antibodies  appear 
to  be kidney tubules,  endocrine  pancreas, and lymphoid 
cells in  the  spleen.  Thus, xenoreactive natural antibodies 
appear to preferentially,  although  not exclusively, recog- 
nize structures expressed by vascular  endothelial cells. 
High background staining by the anti-human Ig anti- 
serum  was observed only in  the spleen. 
with an anti-CD45 mAb) adhering to the vascular endothelial cells and infiltrating the myocardium [arrows) after four cycles of perfusion in the 
FLgure 2. Immunohistochemical analysis of lymphocyte sequestration in the heart. A. Immunoperoxidase staining of human lymphocytes (stained 
presence of 2% heat-inactivated unfractionated human serum (4OOx): B, at a higher magnification (1000~). a CD45 lymphocyte adhering to the 
Capillary endothelium. that appears swollen: C. immunoperoxidase analysis of human NK lymphocytes adhering to the xenogeneic endothelium upon 
perfusion. as described in A. Staining was performed with an anti-CD16 mAb; D. vascular endothelial cells are stained by an anti-human IgG 
polyclonal antlserum after a  20-min perfusion with 2% heat-inactivated human serum. 
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TABLE 1 
Reactivity of human  preformed  natural  antlbodies  with  xenogeneic 
rat  tissues" 
Organ Structures Recognlzed 
Lung Small vessels, capillaries 
Striated muscle 
Spleen 
Small vessels, capillaries 
Lymphoid cells 
Heart 
Kidney 
Small vessels, capillaries 
Pancreas 
Tubular epithelium, capillaries 
Langerhans islets, capillaries 
a Snap-frozen tissue sections were stained with a 1/100 dilution of 
serum, as described in Materials  and  Methods. 
human serum and a peroxidase-conjugated rabbit anti-human Ig anti- 
Leukocyte integrins play major role in lymphocyte 
adhesion  and migration  through  xenogeneic  endothe- 
Zium. To further explore the molecular interactions  un- 
derlying lymphocyte infiltration of the xenogeneic organ, 
purified CD16+CD3- or CD16-CD3+ cells were incubated 
with a combination of anti-CD1 la and anti-CD18 anti- 
bodies before injection into the xenogeneic organ. Figure 
3a shows that  the antibody treatment virtually  abrogates 
lymphocyte witholding in the perfused organ in both 
subsets,  demonstrating a major role of leukocyte integrin 
pathway  in  the adhesion  to and transmigration  through 
xenogeneic endothelium.  Pretreatment of either  subpop- 
ulation  with an isotype-matched control  antibody  (anti- 
pz microglobulin) did not  affect cell sequestration.  These 
findings  are  consistent  with previous in vitro observa- 
tions,  showing that  human leukocyte integrins  can pro- 
ductively interact  with  their xenogeneic ligands  (20). To 
assess  the individual contribution of leukocyte integrins 
to  the sequestration  phenomenon, human lymphocytes 
were  pretreated  with  either anti-CD1 la, anti-CD1 lb,  or 
anti-CD18; Figure 3b shows that the antibody to the 
common ,8 subunit of leukocyte integrins  inhibited cell 
sequestration  with  the  highest efficiency, whereas  anti- 
bodies to individual a-chains showed significant but  less 
efficient  inhibition of cell witholding. These  findings in- 
dicate a role for  both CD1 la/CD18 and  CDllb/CD18  in 
mediating the adhesion of NK cells to xenogeneic endo- 
thelial cells. I t  is noteworthy that also  in the antibody- 
mediated sequestration of CD16+CD3- cells, leukocyte 
integrins represent a critical pathway of lymphocyte 
adhesion  to xenogeneic endothelium. It has recently  been 
shown that  the avidity of LFA-1 for its ligand can be 
Mac 1 antibodies on human T and NK cell recov- 
Figure 3. The effect of anti-LFA-1 and anti- 
ery after rat heart perfusion. a, Purified human 
CD16-CD3+ (round  symbols) or CD16+CD3- 
(square symbols) lymphocytes were circulated 
through the heart in the presence of 2% heat- 
inactivated human serum. Cells were  treated 
with 10 pg/ml of either a combination of anti- 
CDl l a  and anti-CD18 antibodies (empty  sym- 
bols) or an isotype-matched negative control 
mAb lfllled symbols) before injection into the 
heart. Cell counts were performed as described 
in Figure 1 .  Results are representative of three 
separate experiments. b.  Purified human 
CD16TD3- lymphocytes were circulated 
through the heart in the presence of 2% heat- 
inactivated human serum. Before injection in the 
following antibodies: anti-CD1 l a  (round empty 
heart, cells were treated with 1 0  pglml of the 
symbols): antl-CD1 l b  (square  empty  symbols): 
anti-CD18 (round filled symbols). or with an 
isotype-matched control  antibody (squarefilled 
symbol). Cell counts were  performed as de- 
separate experiments. 
scribed above. Results are representative of three 
1 .o 
0.8 
w+ 0.6 3 s 
8 0.4 VI - 
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dramatically up-regulated by triggering the Ag receptor 
complex in  T cells (21). A similar  phenomenon  occurs  in 
CD16+ cells when  the FcyR is cross-linked by specific 
monoclonal antibodies (R. Pardi and J. R. Bender, unpub- 
lished  observations). We postulate that  the recognition of 
endothelial cell-bound, xenoreactive IgG by CD16+ lym- 
phocytes may serve as a triggering mechanism to in- 
crease their binding efficiency to the endothelium via 
LFA-1 and possibly, other leukocyte integrins  expressed 
by this  subset of lymphocytes. 
Comparative phenotypic  analysis of pre- and postper- 
fusion lymphocytes (Table 11) further emphasizes the im- 
portance of LFA-1 in  this process. LFA-1 bright lympho- 
cytes,  which  have been shown  to comprise the  vast ma- 
jority of NK cells and a subset of CD8+ and CD4+ cells 
displaying a "memory" phenotype (22, 23).  are preferen- 
tially retained  in the xenogeneic organ.  The  disappear- 
ance of lymphocytes expressing  high  density of  LFA- 1 is 
clearly detectable after  the  first two perfusion cycles, and 
it is virtually complete within the  10th passage  into the 
coronary  system.  The  mean  relative  ratio of LFA-ld"" vs 
LFA- 1 cells in five different experiments increased 
significantly after two perfusion cycles, and even more 
dramatically after eight  perfusion cycles (Table 11). The 
above data  present evidence that rapid and specific lym- 
phocyte adhesion and  transmigration  through capillary 
endothelium occur in  the xenogeneic human to rat com- 
bination.  This is mainly  due  to the capability of human 
CD16+CD3- NK cells, and a  subset of CD16-CD3+ T cells 
to recognize and traverse  rat  vascular endothelial cells. 
This phenomenon takes place both  in the presence and 
in  the  absence of human IgG (although to a very different 
extent),  indicating that both  antibody-dependent and  an- 
tibody-independent recognition events  capable of trigger- 
ing lymphocyte adhesion and  trans-endothelial cell mi- 
gration are involved. The  results  also  suggest hat xeno- 
reactive IgG, in  addition  to IgM, may have a pathogenetic 
role in hyperacute recognition and rejection of vascular- 
ized xenografts. It is likely that a similar triggering path- 
way might be used by polymorphonuclear cells, which 
express  the low affinity Fcy and  the C3b receptors and 
have been shown to bind to xenogeneic endothelium 
during  hyperacute rejection (4). 
We have previously shown  that,  in allogeneic human 
a 
t 
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o.2 t 
0.0 A 
10 20 30 40 50 60 
Time (min) 
 on January 11, 2010 
www.jimmunol.org
Downloaded from 
XENOGENEIC  TISSUE RECOGNITION BY CIRCULATING LYMPHOCYTES 
TABLE I1 
Relatiue percentages ofLFA-ld"" and LFA-I brfghf lymphocytes upon perfusion  ofxenogeneic heart" 
1421 
Basal Two Cycles 
Expt. 
Eight Cycles 
%bright 7% dull % bright % dull % bright % dull 
1 36 64  23 77 13 87 
2  48 52  22  78 12 88 
3 44 56 25  75  20  80 
4 42  58  24  76 
5 37 63 12 88 
1 1  89 
10 90 
Mean (fSD) 41.4 f 5 58.6 f. 5 78.8 f 6 13.2 f. 4 
Ratlob 
21.2 f 5 
1.44 f. 0.29 4.07 f 1.8' 7.02 f l .Sd 
86.8 f 4 
eight perfusion cycles into the xenogeneic rat heart, as described in Materials and Methods. 
Percentages of LFAld"" and LFA-lbrigh' uman PBL were determined by FACS analysis before (basal) or after two and 
Mean (fSD) ratio of LFA-ld"" vs LFA-lbr'ght lymphocytes. 
p < 0.02. 
p < 0.002. 
systems,  the capability of lymphocytes to adhere to  vas- 
cular endothelial cells correlates  with  the l vel of expres- 
sion of LFA-1 on the effector cells (19,  22,  24). NK cells 
are homogeneously high expressors of LFA-1 and indeed x 150 
adhere avidly to allogeneic endothelia. In the xenogeneic 
system, antibody  inhib ti n  experime ts  have  indicated 8 100 b 
that a  similar  preferential recognition of endothelial cells 
b y  NK cells is evident and the same pathways that are 8 
involved in the adhesion  to  alloendothelia could be  in- 
volved. Unlike the allogeneic system  (25,  26), however, 
the main triggering event for NK cell adhesion to, and 
recognition of, xenogeneic endothelium appears  to be the Time (min) 
50Lil 
j 200 
50 
0 
0 10 20 30 40 50 60 
presence of antibodies bound to the  vascular cells. Anti- 
body-independent recognition of xenoantigens by NK 
cells, if confirmed by further  studies, would support  a 
role for this lymphocyte subset  in early  cellular rejection 
of xenoorgans, such as  skin, not  susceptible  to  hypera- 
cute  humoral rejection. In addition,  our data as well as in 
vitro data from our  laboratory  show that other leukocyte 
integrins,  such as  the  CDllb/CD18, play a role in the 
adhesion of NK cells to  vascular xenogeneic endothelium 
Human NK cells  induce  functional  damage of xeno- 
geneic  organ  and  lyse  xenogeneic  endothelial  cells  in 
uftro. Functional  damage of the  heart  was monitored by 
recording the coronary  pressure  during the experiments. 
Control experiments,  in  which hearts were perfused  with 
either buffer  alone or any of the syngeneic  combinations, 
showed no significant  alterations  (not  shown).  Similarly, 
perfusion of rat  hearts with  either  human Ig or human Ig 
together  with CD3+CD 16- human lymphocytes induced 
only a transient rise  in the coronary  pressure that re- 
verted  to  baseline  values  within 30 min (Fig. 4 b  and not 
shown). However, perfusion of xenogeneic hearts with 
purified NK cells in  the presence of human Ig induced a 
progressive increase  in  the coronary  pressure  during the 
timecourse of the experiment (Fig. 4a) .  
Functional  integrity of the endothelial cell lining  was 
evaluated by perfusing the  heart,  at  the  end of the various 
experiments,  with colloidal carbon  black,  which is a sen- 
sitive marker of increased microvascular permeability 
(28). When the endothelial layer is intact, the dye is 
exclusively localized inside the vessels. However, when 
endothelial  damage  occurs, the dye diffuses  through  the 
endothelial cell junctions  into  the  interstitium  and  sur- 
rounding tissues and is readily detected in the micro- 
scopic specimens. When either buffer alone or buffer 
containing human serum were circulated through the 
heart, no endothelial  damage was ever observed, as as- 
(27). 
Figure4. Coronary pressure profiles during  heart perfusion. Rat 
hearts were isolated and perfused with buffer containing 2% heat-inac- 
tivated unfractionated human serum with (a) or without (b )  NK cells (at 
a starting concentration of lo6 cells/ml). Human Ig alone or human Ig 
with NK cells were injected at time 0 (arrow). 
sessed by the exclusive intravascular localization of col- 
loidal carbon  black (Fig. 50). However, when purified NK 
cells were circulated  along  with human  serum,  carbon 
black extravasation was observed. Figure 5, A and B 
shows  the  extravascular localization of the colloidal dye 
at  the level of the endothelial cell basal  membrane  and 
surrounding  interstitium: at higher magnification (C), the 
colloidal dye can be seen  infiltrating a junction between 
endothelial cells. 
To assess  the role of NK cells in  mediating  direct  dam- 
age of xenogeneic vascular endothelium, 51Cr-labeled 
monolayers of rat  vascular  endothelial cells were cocul- 
tured  in  the presence of human purified NK lymphocytes. 
As  shown  in Figure 6, human NK cells efficiently lyse 
the xenogeneic targets  both  in  the presence of human 
serum and in  the presence of rat  serum. Unlike the lysis 
of the K562 target, however, the  amount of xenogeneic 
endothelial cell lysis is consistently  higher  when human 
serum is used in  the  assay.  This  argues  in favour of a 
contributory role of antibody-dependent cytotoxicity in 
the damage of xenogeneic endothelial cells by NK cells. 
Taken  together, these  data strongly  suggest  a  synergis- 
tic effect of human lymphocytes and xenoreactive natu- 
ral antibodies in mediating functional damage of the 
xenoorgan. Our data point to a possible contribution of 
NK cells in  the early damage of vascular endothelium 
that occurs  in  discordant  xenograft  hyperacute rejection 
in vivo. The role of NK lymphocytes as cellular  effectors 
of graft rejection is also suggested by previous studies 
showing early allograft  invasion by phenotypic and  func- 
tional NK cells (29). and by the  demonstration  that  the 
presence of such cells within the  graft is predictive of 
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serum  and NK cells (A-C)  or buffer containing 2% heat-inactivated  human  serum (D). After 50 min. colloidal carbon  black was added  to the buffer 
FLgure5. Endothelial damage in the perfused rat  heart. Isolated rat hearts were perfused with  buffer  containing 2% heat-inactivated  human 
to achleve  a  final  concentration of 1/200 (v/v).  Four  min  later,  organs  were moved and  samples  were Immediately fixed in 2.5% glutaraldehyde  for 
electron microscopy. A and B show  the  extravasation of the colloidal dye at two  different  magnification (A. 400X: B. 3000x). The  whlte  arrow in A 
indicates an  NK cell adhering  to  the  endothelial  layer.  The  black  arrow  in B is positioned in the dilated  perivascular  space  that  appears filled with 
dye  can  also  be  seen  in  the  surrounding  interstitial  space. D shows  the  exclusive  intravascular localization of the dye in a control  experiment (3000X). carbon black. C shows. at  higher  magnification (30.000~). a junction  between  endothelial  cells  that is infiltrated by carbon  particles  (arrows):  the 
(I . .  lumen; I .  interstitium). 
ing the percentage of NK cells  present  in the reactive foci. 
Furthermore, histologic specimens obtained 4 to 8 wk 
after  engraftment,  as  in  the above  studies, may be inad- 
equate  to  detect  early  events of xenogeneic recognition 
mediated by NK cells. For these  reasons we believe that 
more focused observations  on the  fate of NK cells in the 
early  engraftment of immunodeficient  rodents would be 
required to  define the role of this subpopulation in the 
development of  GVHR. 
In c&clusion, our work demonstrates that a  fraction 
of human lymphocytes comprised in the LFA-lbriKh' pop- 
ulation specifically recognizes the xenogeneic endothe- 
lium and infiltrates the myocardium of the perfused 
30 10 3 1 heart. Recent  vidence has indicated that  the recircula- 
E/Trario tion patterns of naive  (LFA-ldU") and memory (LFA-1 br'Kh') 
T lymphocytes are quite  different,  in that memory cells 
Purified human NK cells were coincubated with "Cr-labeled cultured rat traffic from blood to  peripheral  tissues  whereas  naive 
endothelial  cells  (round  symbols) or K562 cells (square symbols) at the cells selectively traffic from blood to lymph nodes 
indlcated E:T ratios in the  presence of either  human lfflled symbols) or 
rat  (empty  symbols)  heat-inactivated  serum (10% final  concentration). through high postcapillary (33). It is 
Hesults are expressed a s  percent  specific  lysis. a s  described  in  Materfals therefore likely that circulating lymphocytes capable Of  
a n d  Methods. recognizing xenodeterminants  exp essed by vascular  en-
dothelium  also  require a unique  array of adhesion mole- 
subsequent rejection (30). cules, possibly reflecting  a  discrete tage of differentia- 
Interestingly* reports have described the exist- tion,  to  efficiently  traverse the endothelial cell barrier 
ence of a clinical and histopathologic syndrome that and migrate into the xenogeneic tissue. 
closely resembles  a GVHR3 when human PBL from nor- 
Ffgure 6. Human NK cells  efficiently  lyse rat endothelial  cells  in  vitro. 
mal  donors are grafted  into  immunodeficient  rodents (31, Acknowledgments. The authors thank Hugh Auchin- 321. and are Observed In the sites Of closs, Jr., Robin Geller, Jeffrey Platt. and Henry Winn 
GVHR  (liver* skin* etc*)* no  information is given concern- for helpful discussion. We are grateful  to Eugenia Leone - 
:' Abbreviation used in this paper: CVHR. graft vs host reaction. for his-excellent work with EManalysis. 
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